Annual EBITDA:
-$10.50M+$4.69M(+30.87%)Summary
- As of today, XAGE annual EBITDA is -$10.50 million, with the most recent change of +$4.69 million (+30.87%) on December 31, 2024.
- During the last 3 years, XAGE annual EBITDA has fallen by -$6.76 million (-180.96%).
- XAGE annual EBITDA is now -180.96% below its all-time high of -$3.74 million, reached on December 1, 2021.
Performance
XAGE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$1.79M-$360.00K(-25.12%)Summary
- As of today, XAGE quarterly EBITDA is -$1.79 million, with the most recent change of -$360.00 thousand (-25.12%) on June 30, 2025.
- Over the past year, XAGE quarterly EBITDA has dropped by -$659.80 thousand (-58.22%).
Performance
XAGE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$5.57M-$659.80K(-13.43%)Summary
- As of today, XAGE TTM EBITDA is -$5.57 million, with the most recent change of -$659.80 thousand (-13.43%) on June 30, 2025.
- Over the past year, XAGE TTM EBITDA has dropped by -$962.20 thousand (-20.88%).
Performance
XAGE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
XAGE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +30.9% | -58.2% | -20.9% |
| 3Y3 Years | -181.0% | -527.1% | -334.9% |
| 5Y5 Years | -181.0% | -100.0% | -100.0% |
XAGE EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -181.0% | +30.9% | -150.4% | +34.3% | -192.2% | +25.9% |
| 5Y | 5-Year | -181.0% | +30.9% | >-9999.0% | +34.3% | >-9999.0% | +25.9% |
| All-Time | All-Time | -181.0% | +30.9% | >-9999.0% | +34.3% | >-9999.0% | +25.9% |
XAGE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$1.79M(-25.1%) | -$5.57M(-13.4%) |
| Mar 2025 | - | -$1.43M(-48.0%) | -$4.91M(-2.3%) |
| Dec 2024 | -$10.50M(+30.9%) | -$968.30K(+29.7%) | -$4.80M(-25.3%) |
| Sep 2024 | - | -$1.38M(-21.5%) | -$3.83M(+16.8%) |
| Jun 2024 | - | -$1.13M(+14.3%) | -$4.61M(+6.0%) |
| Mar 2024 | - | -$1.32M(+38.6%) | -$4.90M(+34.8%) |
| Dec 2023 | -$15.19M | - | - |
| Sep 2023 | - | -$2.15M(-51.1%) | -$7.52M(-23.6%) |
| Jun 2023 | - | -$1.43M(-17.3%) | -$6.08M(-23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$1.22M(+55.5%) | -$4.95M(-15.9%) |
| Dec 2022 | -$5.06M(-35.4%) | -$2.73M(-281.1%) | -$4.27M(-123.7%) |
| Sep 2022 | - | -$716.00K(-150.4%) | -$1.91M(-48.9%) |
| Jun 2022 | - | -$285.90K(+46.6%) | -$1.28M(-28.7%) |
| Mar 2022 | - | -$535.10K(-44.7%) | -$995.00K(-116.4%) |
| Dec 2021 | -$3.74M | -$369.90K(-311.0%) | -$459.90K(-411.0%) |
| Sep 2021 | - | -$90.00K(>-9900.0%) | -$90.00K(>-9900.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
FAQ
- What is Longevity Health Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Longevity Health Holdings, Inc.?
- What is Longevity Health Holdings, Inc. annual EBITDA year-on-year change?
- What is Longevity Health Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Longevity Health Holdings, Inc.?
- What is Longevity Health Holdings, Inc. quarterly EBITDA year-on-year change?
- What is Longevity Health Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Longevity Health Holdings, Inc.?
- What is Longevity Health Holdings, Inc. TTM EBITDA year-on-year change?
What is Longevity Health Holdings, Inc. annual EBITDA?
The current annual EBITDA of XAGE is -$10.50M
What is the all-time high annual EBITDA for Longevity Health Holdings, Inc.?
Longevity Health Holdings, Inc. all-time high annual EBITDA is -$3.74M
What is Longevity Health Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, XAGE annual EBITDA has changed by +$4.69M (+30.87%)
What is Longevity Health Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of XAGE is -$1.79M
What is the all-time high quarterly EBITDA for Longevity Health Holdings, Inc.?
Longevity Health Holdings, Inc. all-time high quarterly EBITDA is $0.00
What is Longevity Health Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, XAGE quarterly EBITDA has changed by -$659.80K (-58.22%)
What is Longevity Health Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of XAGE is -$5.57M
What is the all-time high TTM EBITDA for Longevity Health Holdings, Inc.?
Longevity Health Holdings, Inc. all-time high TTM EBITDA is $0.00
What is Longevity Health Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, XAGE TTM EBITDA has changed by -$962.20K (-20.88%)